Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer

Juan Du(Wuhan Polytechnic University), Baorui Liu(Nanjing University of Chinese Medicine), Zhengyun Zou(Nanjing University of Chinese Medicine), Linxi Zhu(Wenzhou University), Yudong Qiu(Nanjing Drum Tower Hospital), Weiwei Kong(Nanjing Drum Tower Hospital), Jie Shen(Soochow University), Lixia Yu(Comprehensive Blood & Cancer Center), Lianjun Zhao(Nanjing Drum Tower Hospital), Huizi Sha(Nanjing Drum Tower Hospital), Qing Gu(University of California San Diego)
Frontiers in Oncology
November 1, 2022
10.3389/fonc.2022.1015232
Cited by 1

Related Papers

Lasing action from photonic bound states in continuum
|Nature|2017|1.4k
iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
|Nature Communications|2019|126
Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy
|Nature Communications|2022|102
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response
|Pharmacology & Therapeutics|2022|99
Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota
|Life Sciences|2023|84